Zivo Bioscience Alpha and Beta Analysis
| ZIVODelisted Stock | USD 1.81 0.01 0.55% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Zivo Bioscience. It also helps investors analyze the systematic and unsystematic risks associated with investing in Zivo Bioscience over a specified time horizon. Remember, high Zivo Bioscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Zivo Bioscience's market risk premium analysis include:
Beta (0.80) | Alpha (0.55) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Zivo |
Zivo Bioscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Zivo Bioscience market risk premium is the additional return an investor will receive from holding Zivo Bioscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Zivo Bioscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Zivo Bioscience's performance over market.| α | -0.55 | β | -0.8 |
Zivo Bioscience Fundamentals Vs Peers
Comparing Zivo Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Zivo Bioscience's direct or indirect competition across all of the common fundamentals between Zivo Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Zivo Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Zivo Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Zivo Bioscience to competition |
| Fundamentals | Zivo Bioscience | Peer Average |
| Return On Equity | -39.56 | -0.31 |
| Return On Asset | -1.65 | -0.14 |
| Operating Margin | (133.25) % | (5.51) % |
| Current Valuation | 2.02 M | 16.62 B |
| Shares Outstanding | 1.82 M | 571.82 M |
| Shares Owned By Insiders | 25.23 % | 10.09 % |
| Shares Owned By Institutions | 4.44 % | 39.21 % |
Zivo Bioscience Opportunities
Zivo Bioscience Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | ZIVO Bioscience Price Target and Analyst Ratings 2023 | 05/11/2023 |
2 | Flora Growth to effect 1-for-20 reverse stock split - Seeking Alpha | 06/07/2023 |
3 | Zivo Bioscience Shares Jump Premarket After Dropping Plans for Securities Offering | 06/29/2023 |
4 | ZIVO Bioscience Announces Pricing of 4.0 Million Registered Direct Offering Priced At-The-Market | 06/30/2023 |
About Zivo Bioscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Zivo or other delisted stocks. Alpha measures the amount that position in Zivo Bioscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Zivo Bioscience Upcoming Company Events
As portrayed in its financial statements, the presentation of Zivo Bioscience's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Zivo Bioscience's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Zivo Bioscience's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Zivo Bioscience. Please utilize our Beneish M Score to check the likelihood of Zivo Bioscience's management manipulating its earnings.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Zivo Bioscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |